Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (17767)	3/20/1998 1:49:00 PM
From: Brian Moore	Read Replies (1) \| Respond to of 32384

Bio, Thanks for the references!

To: Pseudo Biologist who wrote (17767)	3/20/1998 7:45:00 PM
From: Brian Moore	Read Replies (1) \| Respond to of 32384

Bio, that link to the Bio Fund ... just read the opening message ... looks really good. Sturza ... ran across a site for him ... includes some samples of his newsletter ... perhaps you've seen it sturzas.com

To: Pseudo Biologist who wrote (17767)	5/15/1998 4:37:00 PM
From: mason630	Read Replies (1) \| Respond to of 32384

I'm wondering what qualifications a person must have (if any) to "analyze" biotechnology companies. Are McCamant, Murphy and Sturza MD's or PhD's? Can just anybody write a newsletter and claim to be an analyst (expert) in biotechnology? I heard that Sturza, for one, is only a journalist with no medical /scientific background at all! In fact, I think he was a writer for a magazine before he started analyzing biotech companies. Are these people affiliated with any brokerage firm? They all seem to have pretty poor track records. It's a wonder anybody listens to them at all!

To: Pseudo Biologist who wrote (17767)	5/15/1998 6:30:00 PM
From: mason630	Respond to of 32384

Dear Mr. Pseudo Biologist: This is in response to your message of March 20 whereby you recommend reading Sturza's newsletter, etc., for advice on investing in Biotech. What qualifications do Sturza, McCamant and Murphy have? Are they MD's or PhD's? Are they analysts? " If so, which firm are they associated with? Sturza was a writer for a magazine before he began "analyzing" biotech companies. Who listens to them and why? They all seem to have bad track records, especially Sturza. You say you've heard "good things" about him? Wasn't he recommending shorting Organogenesis? What is his position now, I wonder.